Even though most of CLL patients with favorable prognostic features, i.e. CD38-, mutated IGHV, absence of chromosome lesions or isolated 13q−, live for long periods without any treatment, some cases may show progression to a more aggressive leukemia. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.